Artículos Científicos

DATE: 2019/05/27
Factors affecting engagement of primary health care professionals and their patients in facilitated access to online alcohol screening and brief intervention
Int J Med Inform. 2019 Jul;127:95-101. doi: 10.1016/j.ijmedinf.2019.04.018. Epub 2019 Apr 24.
AUTHORS: López-Pelayo H, Wallace P, Miquel L, Segura L, Baena B, Barrio P, Colom J, Gual A; EFAR group.
PMID: 31128838
DATE: 2019/04/10
The More You Take It, the Better It Works: Six-Month Results of a Nalmefene Phase-IV Trial
J Clin Med. 2019 Apr 6;8(4):471. doi: 10.3390/jcm8040471.
AUTHORS: Barrio P, Roncero C, Ortega L, Guardia J, Yuguero L, Gual A.
PMID: 30959893
DATE: 2019/03/29
Prediction of Alcohol Relapse Among Liver Transplant Candidates With Less Than 6 Months of Abstinence Using the High-Risk Alcoholism Relapse Score
Liver Transpl. 2019 Aug;25(8):1142-1154. doi: 10.1002/lt.25460. Epub 2019 Jun 25.
AUTHORS: Lombardo-Quezada J, Colmenero J, López-Pelayo H, Gavotti C, Lopez A, Crespo G, Lopez E, Gual A, Lligoña A, Navasa M.
PMID: 30920118
DATE: 2019/03/14
Why Less Is Always More in the Treatment of Alcohol Use Disorders
JAMA Psychiatry. 2019 Apr 1;76(4):359-360. doi: 10.1001/jamapsychiatry.2018.2807.
AUTHORS: Nutt DJ, Gual A, Anderson P, Rehm J.
PMID: 30865234
DATE: 2019/02/28
Cerebellar alterations in cannabis users: A systematic review
Addict Biol. 2019 Nov;24(6):1121-1137. doi: 10.1111/adb.12714. Epub 2019 Feb 27.
AUTHORS: Blithikioti C, Miquel L, Batalla A, Rubio B, Maffei G, Herreros I, Gual A, Verschure P, Balcells-Oliveró M.
PMID: 30811097
DATE: 2019/02/15
Identifying Triggers of Alcohol Craving to Develop Effective Virtual Environments for Cue Exposure Therapy
Front Psychol. 2019 Jan 29;10:74. doi: 10.3389/fpsyg.2019.00074. eCollection 2019.
AUTHORS: Ghiţă A, Teixidor L, Monras M, Ortega L, Mondon S, Gual A, Paredes SM, Villares Urgell L, Porras-García B, Ferrer-García M, Gutiérrez-Maldonado J.
PMID: 30761042
DATE: 2019/01/19
Treatment retention in a specialized alcohol programme after an episode of alcoholic hepatitis: Impact on alcohol relapse
J Psychosom Res. 2019 Jan;116:75-82. doi: 10.1016/j.jpsychores.2018.11.020. Epub 2018 Nov 28.
AUTHORS: López-Pelayo H, Miquel L, Altamirano J, Bataller R, Caballeria J, Ortega L, Lligoña A, Gual A.
PMID: 30654998
DATE: 2018/07/31
A comparison between phase-III trials and a phase-IV study of nalmefene in alcohol use disorder patients. Is there a difference?
Adicciones. 2019 Sep 1;31(4):284-288. doi: 10.20882/adicciones.1046.
AUTHORS: Barrio Giménez P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.
PMID: 30059574
DATE: 2015/08/14
Psychiatric Comorbidity in Treatment-Seeking Alcohol Dependence Patients With and Without ADHD
J Atten Disord. 2019 Oct;23(12):1497-1504. doi: 10.1177/1087054715598841. Epub 2015 Aug 12.
AUTHORS: Roncero C, Ortega L, Pérez-Pazos J, Lligoña A, Abad AC, Gual A, Sorribes M, Grau-López L, Casas M, Daigre C.
PMID: 26269096
DATE: 2018/10/04
Risky Alcohol Use: The Impact on Health Service Use
Eur Addict Res. 2018;24(5):234-244. doi: 10.1159/000493884. Epub 2018 Oct 3.
AUTHORS: Miquel L, Manthey J, Rehm J, Vela E, Bustins M, Segura L, Vieta E, Colom J, Anderson P, Gual A.
PMID: 30282079